Summit Partners Public Asset Management’s Eli Lilly LLY Stock Holding History

Summit Partners Public Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-31,592	Closed	-$24.4M	–	178
2024 Q4	$24.4M	Sell	31,592 -40,913	-56%	-$33.9M	0.47%	64
2024 Q3	$64.2M	Buy	72,505 +4,574	+7%	+$4.11M	1.99%	18
2024 Q2	$61.5M	Buy	67,931 +39,688	+141%	+$31.7M	2.35%	12
2024 Q1	$22M	Sell	28,243 -3,299	-10%	-$2.35M	0.76%	50
2023 Q4	$18.4M	Buy	31,542 +10,241	+48%	+$5.98M	0.76%	51
2023 Q3	$11.4M	Sell	21,301 -50,378	-70%	-$26M	0.5%	75
2023 Q2	$33.6M	Buy	+71,679	New	+$30.1M	1.25%	24

Other funds holding LLY

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Summit Partners Public Asset Management's LLY Position: Q1 2025 in Review

Summit Partners Public Asset Management sold out of Eli Lilly (LLY) in Q1 2025, closing a stake of 31,592 shares — an estimated $24.4M sold.

Summit Partners Public Asset Management first reported a position in LLY in Q2 2023 and held it in 7 quarters. The position peaked at $64.2M in Q3 2024. 3,920 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

Summit Partners Public Asset Management reported no remaining Eli Lilly position as of Q1 2025 after selling out during the quarter.
Summit Partners Public Asset Management sold 31,592 Eli Lilly shares in Q1 2025, an estimated $24.4M.
Summit Partners Public Asset Management first reported a position in Eli Lilly in Q2 2023 and held it in 7 quarters.
Summit Partners Public Asset Management's Eli Lilly position peaked at $64.2M in Q3 2024.
3,920 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on Summit Partners Public Asset Management's 13F filing for Q1 2025, filed 15 May 2025.